Ovarian Cancer - New Study Results

Ovarian Cancer - New Study Results

AI Outperforms Experts in Detecting Ovarian Cancer, New Study Shows #breakingnews #latestnews #newsПодробнее

AI Outperforms Experts in Detecting Ovarian Cancer, New Study Shows #breakingnews #latestnews #news

Latest Developments in Ovarian Cancer Treatment & ManagementПодробнее

Latest Developments in Ovarian Cancer Treatment & Management

REVIEW OF Imunon Inc. ($IMNN) - A Phase 2 Ovarian Cancer Study Results PlayПодробнее

REVIEW OF Imunon Inc. ($IMNN) - A Phase 2 Ovarian Cancer Study Results Play

Report Back from SGO: What’s the Latest in Ovarian Cancer?Подробнее

Report Back from SGO: What’s the Latest in Ovarian Cancer?

AIM CEO Corner: Top line Interim Data from Recurrent Ovarian Cancer Study April 11 2024Подробнее

AIM CEO Corner: Top line Interim Data from Recurrent Ovarian Cancer Study April 11 2024

Integrating New Research Information into Current Clinical Care — Ovarian CancerПодробнее

Integrating New Research Information into Current Clinical Care — Ovarian Cancer

First Line Endometrial Cancer Study Results- 2024 Ovarian Cancer ProgramПодробнее

First Line Endometrial Cancer Study Results- 2024 Ovarian Cancer Program

Research Update: Using Shopping Data to Improve the Diagnosis of Ovarian CancerПодробнее

Research Update: Using Shopping Data to Improve the Diagnosis of Ovarian Cancer

Ovarian Cancer - New Study ResultsПодробнее

Ovarian Cancer - New Study Results

What's New in Ovarian Cancer Research: 2023 UpdatesПодробнее

What's New in Ovarian Cancer Research: 2023 Updates

Organoids: Opening new doors to the study of ovarian cancerПодробнее

Organoids: Opening new doors to the study of ovarian cancer

New Advances in Research & Treatment in Ovarian CancerПодробнее

New Advances in Research & Treatment in Ovarian Cancer

New Ovarian Cancer TestПодробнее

New Ovarian Cancer Test

Nuclear Medicine Treatment Cures Lethal Form of Ovarian Cancer in Preclinical SettingПодробнее

Nuclear Medicine Treatment Cures Lethal Form of Ovarian Cancer in Preclinical Setting

Low-grade serous ovarian cancer: expert consensus report on the state of the science video podcastПодробнее

Low-grade serous ovarian cancer: expert consensus report on the state of the science video podcast

Recurrent Ovarian Cancer (2023)Подробнее

Recurrent Ovarian Cancer (2023)

What’s New with PARP Inhibitors and Ovarian Cancer?Подробнее

What’s New with PARP Inhibitors and Ovarian Cancer?

Predicting Early-Symptoms Of Ovarian Cancer Through A.I. Suggests A Study In China | N18SПодробнее

Predicting Early-Symptoms Of Ovarian Cancer Through A.I. Suggests A Study In China | N18S

2023 Ovarian Cancer Clinical UpdatesПодробнее

2023 Ovarian Cancer Clinical Updates